1. Clinical & Scientific Overview
Amoxicillin Trihydrate (TIP-MED-000129, Reference Code [8.1]) is classified under
Antimicrobials — Antibacterial & Antibiotic Agents (Ch 08) as a Aminopenicillin Beta-Lactam Antibiotic (Bactericidal Cell-Wall Peptidoglycan Synthesis Inhibitor; WHO 'Access' Group).
Within the Indian regulatory and compendial framework, it is governed under Schedule H (Drugs Rules, 1945 — Prescription Only).
Mox (Sun Pharma), Novamox (Cipla), Almox (Alkem)
Oral Capsules / Dispersible Tablets: 250 mg, 500 mg; Paediatric Dry Syrup for Reconstitution: 125 mg/5 mL, 250 mg/5 mL; Drops: 100 mg/mL
3. Mechanism of Action & Pharmacodynamics
Bactericidal time-dependent beta-lactam antibiotic (`fT > MIC`) that binds to bacterial Penicillin-Binding Proteins (PBPs 1A, 2, 3), inhibiting transpeptidation of peptidoglycan cell-wall cross-links and triggering autolysin-mediated bacterial cell lysis.
4. Therapeutic Indications & Evidence-Supported Uses
- Community-acquired respiratory tract infections (acute otitis media, bacterial pharyngotonsillitis, sinusitis, community-acquired pneumonia)
- Helicobacter pylori eradication regimens (in combination with Clarithromycin/Metronidazole and a PPI) and dental abscesses
5. Educational Dosage Context, Formulations & Administration
Educational Dosing & Regimen Summary: Educational Reference Summary: Standard adult oral regimen is 250 mg to 500 mg every 8 hours (TID) or 875 mg every 12 hours (BID) for 5–7 days depending on infection site and severity (H. pylori: 1000 mg BID).
Administration & Meal Timing: May be taken with or without food (taking at the start of a light meal improves GI tolerability, particularly when combined with Clavulanic Acid). Space doses evenly every 8 hours (`fT > MIC` time-dependent killing).
6. Pharmacokinetics, Metabolism & Renal/Hepatic Adjustment
Absorption, distribution, metabolism, and excretion follow class pharmacokinetic profile; verify patient renal/hepatic function.
No routine hepatic dose adjustment required for plain Amoxicillin (monitor LFTs if co-formulated with Clavulanate, which carries cholestatic jaundice risk).
Excreted primarily unchanged via glomerular filtration and tubular secretion: CrCl 10–30 mL/min: 250–500 mg every 12 hours; CrCl < 10 mL/min: 250–500 mg every 24 hours; administer dose after haemodialysis session.
No routine hepatic dose adjustment required for plain Amoxicillin (monitor LFTs if co-formulated with Clavulanate, which carries cholestatic jaundice risk).
7. Contraindications, Precautions & High-Risk Warnings
- History of immediate IgE-mediated hypersensitivity (anaphylaxis, angioedema, bronchospasm, Stevens-Johnson syndrome) to Penicillins or any Beta-Lactam antibiotic
- Avoid in suspected infectious mononucleosis (Epstein-Barr virus) due to >70% incidence of generalised maculopapular morbilliform rash
Key Clinical Precautions: No routine hepatic dose adjustment required for plain Amoxicillin (monitor LFTs if co-formulated with Clavulanate, which carries cholestatic jaundice risk).
8. Adverse Effects Profile
- Hypersensitivity reactions ranging from delayed maculopapular rash to immediate IgE-mediated urticaria and anaphylaxis
- Diarrhoea, nausea, candidal superinfection (oral/vulvovaginal thrush), rare Clostridioides difficile colitis
- Monitor for severe hypersensitivity, organ toxicity, or dose-limiting adverse events.
9. Major Drug–Drug, Drug–Food & Drug–Herb Interactions
- Methotrexate: Penicillins compete for renal organic anion tubular secretion (OAT1/OAT3), reducing Methotrexate clearance and risking severe myelosuppression.
- Allopurinol: Co-administration significantly increases the incidence of non-allergic maculopapular skin rash.
- Warfarin / Oral Anticoagulants: Alteration of gut flora may potentiate INR elevation; monitor INR during systemic antibiotic therapy.
10. Clinical Monitoring, Patient Counselling & Storage
Clinical & Laboratory Monitoring: Monitor clinical response, baseline renal/hepatic parameters, and relevant serum biomarkers.
Pharmacist Patient Counselling Points:
- Always confirm absence of Penicillin allergy before dispensing the first dose.
- Complete the full prescribed antibiotic course at evenly spaced intervals (every 8 hours for TID) even if fever subsides after 48 hours.
- For paediatric dry syrup powder: reconstitute to the ring mark with boiled and cooled water, shake well before each dose, and discard unused suspension after 7–10 days (per manufacturer label).
Storage, Stability & Dispensing Safeguards: Store capsules below 25°C in a dry place; reconstituted oral suspensions should be stored in a cool place / refrigerator (2°C–8°C) and discarded after 7–14 days.
11. Visual Pharmacology & Mechanism Diagram (svg-v339-01-adme-12-step-journey)
12. Authoritative References, Regulatory Sources & Editorial Disclaimer
Primary Compendial & Guideline Reference: Indian Pharmacist Desk Reference — Professional Edition 2.7 (2026–27) by Tejas Nartam; ICMR Antimicrobial Treatment Guidelines; NFI 7th Ed (2026).
Official Verification Portals: Indian Pharmacopoeia Commission (IPC) & National Formulary of India (NFI) • Central Drugs Standard Control Organization (CDSCO) • Ministry of Health & Family Welfare — NLEM 2022 • NCBI Bookshelf / StatPearls Pharmacology Reference • DailyMed (US FDA Official Prescribing Reference)
Last Medically & Pharmaceutically Reviewed: 2026-11-10 • Verification Status: VERIFIED_EDUCATIONAL_CONTENT
Educational & Clinical Disclaimer: This reference profile is published solely for pharmacy education, academic study, and professional clinical reference. It does not substitute for patient-specific clinical judgement, qualified specialist oncology/medical supervision, or official CDSCO/IP prescribing information. Never self-medicate with prescription, Schedule H/H1/X, NDPS, or oncology medicines.